719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer

by Tyler Curiel, Yilun Deng, Ryan Reyes, Aravind Kancharla, Myrna Garcia, Harshita Gupta, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler, Anand Kornepati, Robert Svatek
Published 2020-11-01

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

by Yilun Deng, Aravind Kancharla, Myrna Garcia, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler, Tyler J Curiel, Robert S Svatek, Ryan Michael Reyes, Harshita B Gupta, Alvaro S Padron, Chenghao Zhang, Anand V R Kornepati, Onur Boyman, Jose R Conejo-Garcia
Published 2021-04-01